Decoding the molecular drivers of TP53 ‐mutant acute myeloid leukaemia: Clinical implications and prognostic insights

Documenti analoghi

• Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights
  di: Boaz Nachmias, et al.
  Pubblicazione: (2024)
• Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemia
  di: Li‐Xin Wu, et al.
  Pubblicazione: (2025)
• Somatic co‐alteration signatures are prognostic in high‐grade TP53‐mutated myeloid neoplasms
  di: Emily O. Symes, et al.
  Pubblicazione: (2024)
• A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction
  di: Cesar Alexander Ortiz Rojas, et al.
  Pubblicazione: (2024)
• Long‐term remission of TP53‐mutated therapy‐related acute myeloid leukaemia following allogeneic stem cell transplantation in a heart transplant recipient: A case report and literature review
  di: Annie Xiao, et al.
  Pubblicazione: (2024)